CN Stock MarketDetailed Quotes

Yili Chuanning Biotechnology (301301)

Watchlist
  • 10.03
  • +0.27+2.77%
Market Closed Apr 30 15:00 CST
22.37BMarket Cap37.85P/E (TTM)

Yili Chuanning Biotechnology (301301) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical intermediates4.15B89.92%
Other business389.55M8.44%
Other products75.71M1.64%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry4.23B91.56%
Other business389.55M8.44%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China1.87B40.53%
North China884.49M19.16%
Exit624.44M13.53%
South China490.59M10.63%
Northwest405.23M8.78%
Central China230.71M5.00%
Southwest86.77M1.88%
Northeast China23.3M0.50%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More